Surgical palliation in pancreatic cancer

Minerva Chirurgica

Volumn 59, Issue 2, 2004, Pages 137-149

  Kuhlmann, K F D ^a   De Castro, S M M ^a   Gouma, D J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Pancreatic neoplasms, diagnosis; Pancreatic neoplasms, surgery; Surgical palliation

Indexed keywords

ADVANCED CANCER; CANCER DIAGNOSIS; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER SURGERY; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; OBSTRUCTIVE JAUNDICE; PANCREAS CANCER; PROGNOSIS; QUALITY OF LIFE; REVIEW; STOMACH OBSTRUCTION; SYMPTOMATOLOGY;

ABDOMINAL PAIN; COHORT STUDIES; DIGESTIVE SYSTEM SURGICAL PROCEDURES; GASTRIC OUTLET OBSTRUCTION; HUMANS; JAUNDICE, OBSTRUCTIVE; LAPAROSCOPY; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 4043165468     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
2. DiMagno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 1999;117:1464-84.
3. Kuhlmann KF, de Castro SM, Wesseling JG, ten Kate FJ, Offerhaus GJ, Busch OR et al. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer 2004;40:549-58.
4. Gudjonsson B. Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg 1995;181:483-503.
5. Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999;189:1-7.
6. Tan HP, Smith J, Garberoglio CA. Pancreatic adenocarcinoma: an update. J Am Coll Surg 1996;183:164-84.
7. World Health Organisation. National Cancer Control Programmes: policies and managerial guidlines. 2002.
8. Palazzo L. Imaging and staging of bilio-pancreatic tumours: role of endoscopic and intraductal ultrasonography and guided cytology. Ann Oncol 1999;10 Suppl 4:25-7.
9. McCarthy MJ, Evans J, Sagar G, Neoptolemos JP. Prediction of resectability of pancreatic malignancy by computed tomography. Br J Surg 1998;85:320-5.
10. Bemelman WA, de Wit LT, van Delden OM, Smits NJ, Obertop H, Rauws EJ et al. Diagnostic laparoscopy combined with laparoscopic ultrasonography in staging of cancer of the pancreatic head region. Br J Surg 1995;82:820-4.
11. Friess H, Kleeff J, Silva JC, Sadowski C, Baer HU, Buchler MW. The role of diagnostic laparoscopy in pancreatic and periampullary malignancies. J Am Coll Surg 1998;186:675-82.
12. Nieveen van Dijkum EJ, Romijn MG, Terwee CB, de Wit LT, van der Meulen JH, Lameris HS et al. Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg 2003;237:66-73.
13. Pisters PW, Lee JE, Vauthey JN, Charnsangavej C, Evans DB. Laparoscopy in the staging of pancreatic cancer. Br J Surg 2001;88:325-37.
14. Sohn TA, Lillemoe KD, Cameron JL, Huang JJ, Pitt HA, Yeo CJ. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s. J Am Coll Surg 1999;188:658-66.
15. Andren-Sandberg A. Pain relief in pancreatic disease. Br J Surg 1997;84:1041-2.
16. World Health Organization. Cancer Pain Relief. Geneva: WHO; 1986.
17. Caraceni A, Portenoy RK. Pain management in patients with pancreatic carcinoma. Cancer 1996;78:639-53.
18. Alter CL. Palliative and supportive care of patients with pancreatic cancer. Semin Oncol 1996;23:229-40.
19. Kappis M. Erfahrungen mit localanasthesie bei bauchoperationen. Verh Dtsch Geselsch Chir 1914;43:87-9.
20. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg 1995;80:290-5.
21. Lillemoe KD, Cameron JL, Kaufman HS, Yeo CJ, Pitt HA, Sauter PK. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 1993;217:447-55.
22. Kelsen DP, Portenoy R, Thaler H, Tao Y, Brennan M. Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery 1997;122:53-9.
23. van Geenen RC, Keyzer-Dekker CM, van Tienhoven G, Obertop H, Gouma DJ. Pain management of patients with unresectable peripancreatic carcinoma. World J Surg 2002;26:715-20.
24. Polati E, Finco G, Gottin L, Bassi C, Pederzoli P, Ischia S. Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br J Surg 1998;85:199-201.
25. Ischia S, Ischia A, Polati E, Finco G. Three posterior percutaneous celiac plexus block techniques. A prospective, randomized study in 61 patients with pancreatic cancer pain. Anesthesiology 1992;76:534-40.
26. Wong GY, Schroeder DR, Carns PE, Wilson JL, Martin DP, Kinney MO et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 2004;291:1092-9.
27. Ihse I, Zoucas E, Gyllstedt E, Lillo-Gil R, Andren-Sandberg A. Bilateral thoracoscopic splanchnicectomy: effects on pancreatic pain and function. Ann Surg 1999;230:785-90.
28. Ceha HM, van Tienhoven G, Gouma DJ, Veenhof CH, Schneider CJ, Rauws EA et al. Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma. Cancer 2000;89:2222-9.
29. Shinchi H, Takao S, Noma H, Matsuo Y, Mataki Y, Mori S et al. Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2002;53:146-50.
30. Abraham NS, Barkun JS, Barkun AN. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc 2002;56:835-41.
31. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992;340:1488-92.
32. Kaassis M, Boyer J, Dumas R, Ponchon T, Coumaros D, Delcenserie R et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 2003;57:178-82.
33. Rappaport MD, Villalba M. A comparison of cholecysto- and choledochoenterostomy for obstructing pancreatic cancer. Am Surg 1990;56:433-5.
34. Sarfeh IJ, Rypins EB, Jakowatz JG, Juler GL. A prospective, randomized clinical investigation of cholecystoenterostomy and choledochoenterostomy. Am J Surg 1988;155:411-4.
35. Di Fronzo LA, Cymerman J, Egrari S, O'Connell TX. Unresectable pancreatic carcinoma: correlating length of survival with choice of palliative bypass. Am Surg 1999;65:955-8.
36. Potts JR, III, Broughan TA, Hermann RE. Palliative operations for pancreatic carcinoma. Am J Surg 1990;159:72-7.
37. Shepherd HA, Royle G, Ross AP, Diba A, Arthur M, Colin-Jones D. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. BrJ Surg 1988;75:1166-8.
38. Andersen JR, Sorensen SM, Kruse A, Rokkjaer M, Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989;30:1132-5.
39. Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 1994;344:1655-60.
40. Taylor MC, McLeod RS, Langer B. Biliary stenting versus bypass surgery for the palliation of malignant distal bile duct obstruction: a meta-analysis. Liver Transpl 2000;6:302-8.
41. Thor PJ, Popiela T, Sobocki J, Herman RM, Matyja A, Huszno B. Pancreatic carcinoma-induced changes in gastric myoelectric activity and emptying. Hepatogastroenterology 2002;49:268-70.
42. Yeo CJ, Barry MK, Sauter PK, Sostre S, Lillemoe KD, Pitt HA et al. Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg 1993;218:229-37.
43. Singh SM, Longmire WP Jr, Reber HA. Surgical palliation for pancreatic cancer. The UCLA experience. Ann Surg 1990;212:132-9.
44. Lillemoe KD, Cameron JL, Hardacre JM, Sohn TA, Sauter PK, Coleman J et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999;230:322-8.
45. Espat NJ, Brennan MF, Conlon KC. Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass. J Am Coll Surg 1999;188:649-55.
46. van Heek NT, De Castro SM, van Eijck CH, van Geenen RC, Hesselink EJ, Breslau PJ et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 2003;238:894-902.
47. Rhodes M, Nathanson L, Fielding G. Laparoscopic biliary and gastric bypass: a useful adjunct in the treatment of carcinoma of the pancreas. Gut 1995;36:778-80.
48. Rothlin MA, Schob O, Weber M. Laparoscopic gastro- and hepaticojejunostomy for palliation of pancreatic cancer: a case controlled study. Surg Endosc 1999;13:1065-9.
49. Kuriansky J, Saenz A, Astudillo E, Cardona V, Fernandez-Cruz L. Simultaneous laparoscopic biliary and retrocolic gastric bypass in patients with unresectable carcinoma of the pancreas. Surg Endosc 2000;14:179-81.
50. Nassif T, Prat F, Meduri B, Fritsch J, Choury AD, Dumont JL et al. Endoscopic palliation of malignant gastric outlet obstruction using self-expandable metallic stents: results of a multicenter study. Endoscopy 2003;35:483-9.
51. Wong YT, Brains DM, Munson L, Sanders L, Heiss F, Chase M et al. Gastric outlet obstruction secondary to pancreatic cancer: surgical vs endoscopic palliation. Surg Endosc 2002;16:310-2.
52. Mittal A, Windsor J, Woodfield J, Casey P, Lane M. Matched study of three methods for palliation of malignant pyloroduodenal obstruction. Br J Surg 2004;91:205-9.
53. Reinders ME, Allema JH, van Gulik TM, Karsten TM, de Wit LT, Verbeek PC et al. Outcome of microscopically nonradical, subtotal pancreaticoduodenectomy (Whipple's resection) for treatment of pancreatic head tumors. World J Surg 1995;19:410-4.
54. Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeeb A, Sauter PK et al. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg 1996;223:718-25.
55. Gouma DJ, Van Dijkum EJ, van Geenen RC, van Gulik TM, Obertop H. Are there indications for palliative resection in pancreatic cancer? World J Surg 1999;23:954-9.
56. Crile G jr. The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet 1970;130:1049-53.
57. Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993;217:430-5.